研究業績

消化器内科

消化器内科業績

  1. Suzuki S, Iwaizumi M, Yamada H, Sugiyama T, Hamaya Y, Furuta T, Kanaoka S, Sugimura H, Miyajima H, Osawa S, Carethers JM, Sugimoto K: MBD4 frameshift mutation caused by DNA mismatch repair deficiency enhances cytotoxicity by trifluridine, an active antitumor agent of TAS-102, in colorectal cancer cells. Oncotarget 15:11477-11488, 2017.
  2. Kagami T, Yamade M, Suzuki T, Uotani T, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Umemura K, Miyajima H, Furuta T. Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype.Clin Pharmacol Ther. 2018 May;103(5):906-913. doi: 10.1002/cpt.863. Epub 2017 Oct 13.
  3. Tani S, Takano R, Tamura S, Oishi S, Iwaizumi M, Hamaya Y, Takagaki K, Nagata T, Seto S, Horii T, Kosugi I, Iwashita T, Osawa S, Furuta T, Miyajima H, Sugimoto K: Digoxin Attenuates Murine Experimental Colitis by Downregulating Th17-related Cytokines. Inflamm Bowel Dis 23: 728-738, 2017.
英文業績
  1. Suzuki S, Iwaizumi M, Yamada H, Sugiyama T, Hamaya Y, Furuta T, Kanaoka S, Sugimura H, Miyajima H, Osawa S, Carethers JM, Sugimoto K: MBD4 frameshift mutation caused by DNA mismatch repair deficiency enhances cytotoxicity by trifluridine, an active antitumor agent of TAS-102, in colorectal cancer cells. Oncotarget 15:11477-11488, 2017.
  2. Kagami T, Yamade M, Suzuki T, Uotani T, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Umemura K, Miyajima H, Furuta T. Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype.Clin Pharmacol Ther. 2018 May;103(5):906-913. doi: 10.1002/cpt.863. Epub 2017 Oct 13.
  3. Tani S, Takano R, Tamura S, Oishi S, Iwaizumi M, Hamaya Y, Takagaki K, Nagata T, Seto S, Horii T, Kosugi I, Iwashita T, Osawa S, Furuta T, Miyajima H, Sugimoto K: Digoxin Attenuates Murine Experimental Colitis by Downregulating Th17-related Cytokines. Inflamm Bowel Dis 23: 728-738, 2017.
  4. Furuta T, Sugimoto M, Kodaira C, Nishino M, Yamade M, Uotani T, Sahara S, Ichikawa H, Kagami T, Iwaizumi M, Hamaya Y, Osawa S, Sugimoto K, Umemura K: Influence of low-dose proton pump inhibitors administered concomitantly or separately on the anti-platelet function of clopidogrel. J Thromb Thrombolysis 43: 333-342, 2017.
  5. Sahara S, Sugimoto M*, Ichikawa H, Kagami T, Sakao Y, Ohashi N, Horio Y, Sugimoto K, Kato A, Furuta T, Yasuda H. Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial. Digestion. 2018;97(2):163-169.
  6. Iida T, Ikeya K, Kato M, Abe J, Yamamoto M, Watanabe F, Sugimoto K, Hanai H: Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice. Digestion 96: 119-126, 2017.
  7. Sugimoto M, Sahara S, Ichikawa H, Sakao Y, Ohashi N, Sugimoto K, Yasuda H, Furuta T, Andoh A: Natural Course of Helicobacter pylori Infection in Japanese Hemodialysis Patients. Digestion 95: 302-309, 2017.
  8. Mori M, Genda T, Ichida T, Murata A, Kamei M, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Ishikawa S, Kikuchi T, Shimada Y, Hirano K, Iijima K, Sugimoto K, Wada R, Nagahara A, Watanabe S: Aldo-keto reductase family 1 member B10 is associated with hepatitis B virus-related hepatocellular carcinoma risk. Hepatol Res 47: E85-E93, 2017.
  9. Yamada Y, Sugimoto K, Yoshizawa Y, Arai Y, Otsuki Y, Arai T, Kobayashi Y, Sato Y, Hosoda Y: Mesenteric inflammatory veno-occlusive disease occurring during the course of ulcerative colitis: a case report. BMC Gastroenterol 11;18(1):9, 2018
 
邦文総説など
  1. 市川 仁美, 杉本 光繁, 安田 日出夫, 佐原 秀, 坂尾 幸俊, 大橋 温, 杉本 健:透析症例におけるグレリンおよび栄養マーカーに対するHelicobacter pylori除菌療法の功績. 日本透析医会雑誌32巻2号:346-352, 2017